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AngioplastyAbstract Background: Management of carotid artery stenosis is considered an important strategy
for stroke prevention. Carotid artery stenting (CAS) has been introduced as an acceptable alterna-
tive to surgical carotid endarterectomy (CEA) in the treatment of internal carotid artery (ICA) ste-
nosis.
Objective: Assessment of peri-procedural outcome of CAS in 104 consecutive procedures.
Methods: The study included 104 consecutive CAS procedures. Included patients hadP50% ICA
stenosis in the symptomatic group andP70% stenosis in the asymptomatic group. Procedures were
performed in cath. labs of Catania and Ragusa hospitals-Italy.
Results: Included procedures were done in 100 consecutive eligible patients with ICA stenosis.
Four patients had undergone CAS procedures in both sides in 2 separate sessions. Patients were
71 males and 29 females, mean age was 71.9 ± 7.85 years, and 21 patients were P80 years old
(octogenarians). The majority of patients had asymptomatic ICA stenosis (76%) and was diagnosed
164 M.A. Ahmad et al.accidentally during medical checkup. Twenty-four patients had symptomatic ICA stenosis (ipsilat-
eral TIA or stroke). Technical success was obtained in 103 procedures (99%). Embolic protection
devices were used in all succeeded cases. Combined cerebrovascular events had occurred in 5
patients with estimated rate = 4.8%. No cases of amaurosis fugax, MI or death had occurred.
Adverse events was 4.1% in the symptomatic group and 1.3% in the asymptomatic group with
no signiﬁcant statistical difference (P= 0.064).
Conclusion: CAS with EPDs seems a feasible and safe procedure and could be performed with an
acceptable rate of periprocedural adverse events.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Cardiology.1. Introduction
Cerebrovascular stroke is the leading cause of long-term dis-
ability and the third leading cause of death after cardiac and
cancer-related deaths in the developed countries.1 There are
two main types of stroke: ischemic and hemorrhagic strokes.
The major cause of ischemic stroke is related to large vessel
atherosclerosis (accounting for one-third of all strokes), with
the highest risk associated with stenosis of the internal carotid
arteries (ICA) that may account for up to 20% of ischemic
cerebrovascular events, and it is considered one of the treatable
causes of initial and recurrent strokes.2 Management of carotid
bifurcation stenosis represents an important strategy in stroke
prevention and has been subjected to extensive clinical investi-
gations, including multiple controlled randomized trials.3 Car-
otid endarterectomy (CEA) has been shown to be superior to
medical treatment in reducing the overall risk of stroke espe-
cially in symptomatic patients with signiﬁcant carotid artery
stenosis.4 However, surgery is not free from complications
especially in high surgical risk patients. CAS has been pro-
posed as a valid alternative to surgery, and two randomized
studies comparing CAS and CEA had shown comparable re-
sults even without embolic protection devices (EPDs).5,6 Re-
cent randomized controlled trial; Carotid Revascularization
Endarterectomy versus Stenting Trial (CREST)7 showed non
inferiority of CAS in relation to CEA. Adverse anatomical fea-
tures of the aortic arch and culprit carotid lesions as well as el-
derly patients were associated with an increased rate of
neurological adverse events during the CAS procedures.8
2. Objective
The aim of the study was to determine the peri-procedural out-
come of CAS in 104 consecutive procedures in order to evalu-
ate the safety of the procedure.
3. Patients and methods
The study included 104 consecutive CAS procedures. Patients
were classiﬁed as symptomatic or asymptomatic based on the
presence or absence of ipsilateral symptoms (Transient Ische-
mic Attack (TIA), Stroke, or amaurosis fugax) related to the
culprit carotid artery stenosis within the last 6 months before
the procedure. Carotid angioplasty was performed in catheter-
ization labs in Catania and Ragusa hospitals-Italy during the
period from October 2009 to May 2011. Procedures were car-
ried out by 2 main operators who have a good experience in
carotid angioplasty and each performs about 50 procedures
per year.3.1. Inclusion criteria
 Symptomatic patients with P50% stenosis of ICA.
 Asymptomatic patients with P70% stenosis of ICA.
Assessment of the degree of ICA stenosis was done in the
angiographic views that showed the minimal luminal diameter.
Measurement was done according to NASCET method (the
distal ICA is the reference diameter).9
3.2. Exclusion criteria
 Total occlusion and pre-occlusive ICA lesions with trickle
antegrade ﬂow (String sign).
 Lesions that showed evidence of thrombi by carotid duplex
or angiography.
 Lesions due to in-stent restenosis.
 Lesions that showed heavy circumferential calciﬁcations.
 Peripheral vascular disease precluding femoral artery
access.
 Major neurological deﬁcit.
3.3. Pre-procedure
Patients underwent thorough clinical examination including
full neurological assessment. Carotid Duplex was performed
in all patients within 1 week before the CAS procedures for
the evaluation of plaque characteristics and degree of stenosis.
Laboratory tests including blood urea, serum creatinine, pro-
thrombin time and concentration were performed before the
procedures. Patients were asked to stop oral intake about 6 h
before the procedures. All patients were on aspirin and
Clopidogrel.
3.4. Intra-procedure
All procedures were performed through femoral access using lo-
cal anesthesia. No sedation was given before or throughout the
procedure in order to keep the conscious level as an early indica-
tor for any complications. A bolus of unfractionated heparin
(70 IU/kg) was given inside the femoral sheath; further boluses
were given as needed to maintain the activated clotting time be-
tween 200 and 250 s. ECG was monitored continuously during
the procedures. Atropine (1 mg IV) was given routinely just be-
fore the post-stenting dilation phase in order to reduce the bra-
Table 1 Demographic and clinical characteristics of the
patients.
Character Number of patients
Age (years)
Mean ± SD 71.9 ± 7.85
Gender
Male patients 71 (71%)
Risk factors
Hypertension 86 (86%)
Diabetes mellitus 42 (42%)
IHD 70 (70%)
Dyslipidemia 94 (94%)
Contralateral CAS 7 (7%)
Contralateral CEA 4 (4%)
Previous PCI 46 (46%)
Previous CABG 10 (10%)
Positive FH 71 (71%)
Current smokers 20 (20%)
Ex smokers 58 (58%)
Non smokers 22 (22%)
Other PAD 18 (18%)
AF 11 (11%)
Reduced LVEF (<40%) 17 (17%)
Neurological symptoms
Asymptomatic patients 76 (76%)
TIA 20 (20%)
Non disabling stroke 4 (4%)
CAS= carotid artery stenting, CEA= carotid endarterectomy,
PCI = percutaneous coronary intervention, CABG= coronary
artery bypass graft, PAD= peripheral arterial disease, AF = atrial
ﬁbrillation, LVEF = left ventricular ejection fraction and
TIA= transient ischemic attack.
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dilation.
All CAS procedures were done using EPDs. Choice be-
tween distal protection (Filters) and proximal protection
(MoMa) was based on the anatomical features of culprit caro-
tid lesions. Predilation with a small coronary balloon was done
only in cases with tight stenotic lesions. Self expandable stents
were used followed by post stenting dilation using a soft under
sized balloon. Selection of stent design (open, closed or hybrid
cell) was based on the morphology of the plaque as well as
angulation of ICA take-off.
Ipsilateral cerebral angiography was done at the end of pro-
cedure for the evaluation of any new abnormalities.
3.5. Post-procedure
All patients were maintained on clopidogrel 75 mg/day for
1 month and ASA 100 mg/day indeﬁnitely. Neurological
examination was done immediately after the procedure and
daily during intra-hospital stay. Major stroke is deﬁned as a
new neurological deﬁcit that persisted after 30 days and that
changed the ‘‘National Institute of Health Stroke Scale’’
NIHSS by >4 points, while minor stroke is a new neurological
deﬁcit that either resolved completely or returned to the base-
line within 30 days, or that changed the NIHSS by 2 or 3
points.
Patients with neurological symptoms were assessed by spe-
cialized neurologists, on the other hand, asymptomatic pa-
tients were examined by cardiologists.
All patients were arranged for clinical follow up in the out-
patient clinic, 30 days after the procedure or in case of develop-
ment of new neurological symptoms.
3.6. Statistical analysis
All baseline demographics, risk factors, procedural data and
angiographic measurements as well as data of 30-day follow
up visit were recorded. Data were collected in Excel database
sheet and statistical analyses were performed with SPSS (ver-
sion 18; SPSS Inc.). Qualitative data were presented as number
and percent and were analyzed using Chi-Square test. Quanti-
tative data were presented as mean ± SD. P< 0.05 was con-
sidered to be statistically signiﬁcant.
4. Results
4.1. Demographics and clinical data
The study included 104 lesions in 100 consecutive eligible pa-
tients. Four patients were subjected to CAS procedures on
both sides in two separate sessions. Patients were 71 (71%)
males and 29 (29%) females. Mean age was 71.9 ± 7.85 years
with 21 patients who were P80 years old (octogenarians). Pa-
tients had risk factors for atherosclerosis as hypertension
(HTN) (86%), diabetes mellitus (DM) (42%), ischemic heart
disease (IHD) (70%) and dyslipidemia (94%). Past history of
contralateral CAS was seen in 7 (7%) patients, contralateral
CEA in 4 (4%) patients, PCI in 46 (46%) patients and CABG
in 10 (10%) patients. Positive family history of atherosclerosis
was found in 71 patients. History suggestive of peripheral arte-rial disease was noticed in 18 (18%) patients. Atrial ﬁbrillation
(AF) was detected in 11 (11%) patients and reduced left ven-
tricular ejection fraction (LVEF) in 17 (17%) patients. Asymp-
tomatic group included 76 (76%) patients while the
symptomatic group included 24 (24%) patients (TIA in 20 pa-
tients and non disabling stroke in 4 patients) (Table 1).
4.2. Procedural and angiographic ﬁndings
Technical success (deﬁned as the performance of PTA and
stenting with ﬁnal residual stenosis <30% with normal ante-
grade ﬂow) was obtained in 103 (99.0%) procedures while
there was failure of 1 (0.9%) procedure because of inability
to achieve selective cannulation and advancement of the long
introducer or guiding catheter through the left CCA due to
presence of complex Type III aortic arch and angulated left
common carotid artery (CCA) take-off.
4.3. Aortic arch angiography
Aortic arch angiography showed diffuse calciﬁcations in 74
(71.1%) cases. Type I aortic arch in 86 (82.6%) cases, Type
II in 15 (14.4%) cases, and Type III in 3 (2.8%) cases. Bovine
arch was found in 9 (8.7%) cases and angulated origin of the
ipsilateral CCA in 18 (17.3%) cases.
Figure 1 Carotid angiograms form case number 42 in RAO 50
projection; (A) Ulcerated plaque with 99% stenosis in the
proximal right ICA. Balloon of MoMa device is seen occluding
ECA. (B) MoMa balloons occluding both CCA and ECA and
lesion pre-dilatation using small coronary balloon (2.0 · 20 mm).
(C) Post dilatation of the stent with undersized balloon
(5.5 · 20 mm) at low pressure. (D) Finale angiographic image
after deﬂation of MoMa balloons; shows good result with less
than 10% residual stenosis.
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angiography (Table 2)
Mean ± SD percentage of ICA stenosis was 81.6 ± 9.8%.
Minimum ICA stenosis was 60% and maximum stenosis was
99%. Mean ± SD length of the lesion was 21.9 ± 4.4 mm.
The study included right ICA stenting in 50 (48.1%) proce-
dures and left ICA stenting in 54 (51.9%) procedures. Site of
maximum stenosis was ostial ICA in 40 (38.5%) lesions and
proximal ICA in 64 (61.5%) lesions. Ulcerated plaque
(Fig. 1A) was detected in 32 (30.8%) lesions and calciﬁed pla-
que was seen in 42 (40.4%) lesions. Tortuous distal ICA was
seen in 61 (58.7%) cases and diseased ECA was seen in 11
(10.6%) lesions. Contralateral complete ICA occlusion was
found in 3 (3%) patients.
4.5. Data of CAS procedures (Table 3)
Four types of EPDs were used in the current study; proximal
protection device (MoMa) was used in 42 (40.8%) procedures
while distal protection ﬁlters were used in the remaining proce-
dures (59.2%); Spider ﬁlter was used in 50 (48.5%) procedures,
Emboshield ﬁlter was used in 9 (8.7%) procedures and Accu-
net ﬁlter was used in 2 (1.9%) procedures.
In cases with proximal protection (MoMa) the mean
clamping time was 5.9 ± 3.1 min, and mean pressure in the
ICA distal to occlusion (back pressure) was
53.2 ± 4.12 mmHg. Two cases (5% of MoMa procedures)
had experienced intolerance to ICA occlusion in the form of
irritability. Both cases had complained by the end of proce-
dures and complete recovery occurred immediately after resto-
ration of ICA blood ﬂow. The contralateral ICA had
insigniﬁcant stenosis in both cases.
In all succeeded procedures, self expandable stents were de-
ployed over the lesion and covering the site of carotid bifurca-
tion, followed by post dilation with a soft under sized balloon
(usually 5–6 mm in diameter) at 6–8 atmosphere.
Stents with open cell design were used in 81 (78.6%) proce-
dures, stents with closed cell design were used in 9 (8.7%) pro-
cedures and stents with hybrid cell design were used in 13
(12.5%) procedures. Direct stenting was done in 88 (85.4%)
procedures, and pre dilation with a small coronary balloon
(2–3 mm in diameter) was done in 15 (14.6%) procedures with
tight ICA stenosis. All cases that necessitated pre dilation were
done under the embolic protection of MoMa device.Table 2 Findings of carotid angiography.
Findings Number (%)
Degree of stenosis (mean ± SD) 81.6 ± 9.8
Length of the lesion in mm (mean ± SD) 21.9 ± 4.4
Side of the lesion right ICA stenosis 50 (48.1%)
Left ICA stenosis 54 (51.9%)
Contra lateral total ICA occlusion 3 (2.8%)
Ostial ICA lesions 40 (38.5%)
Proximal ICA lesions 64 (61.5%)
Lesion ulceration 32 (30.8%)
Lesion calciﬁcations 42 (40.4%)
Distal ICA tortuosity 61 (58.7%)
Diseased ECA 11 (10.6%)4.6. Peri-procedural events
Total cerebrovascular (CV) events occurred in 5 (4.8%) proce-
dures. These CV events consisted of 1 (0.9%) contralateral ma-
jor stroke, 1 (0.9%) ipsilateral minor stroke and 3 (2.8%)
ipsilateral TIAs. No cases of retinal symptoms, MI or death
were reported during the peri-procedural period (Table 4).
4.6.1. Minor complications
One case (0.9%) had suffered prolonged hypotension and was
controlled by positive inotropic drugs for a few hours and
stoppage of antihypertensive medications in the ﬁrst week after
the procedure, thereafter, a smaller dose of antihypertensive
drugs was resumed. One case (0.9%) had a transient attack
of cardiac asystole during balloon post dilation despite of
1 mg IV atropine; the attack lasted less than 20 s and recovered
after another bolus of IV atropine. Two cases showed a post
procedural ICA spasm which was relieved by injection of bolus
of 100 lg of nitrate intra carotid. One case had femoral access
minor hematoma due to failure of vascular closure device and
was controlled by reversal of heparin and manual
compression.
19
76
2 3
0
10
20
30
40
50
60
70
80
≥ 80 year-old patients < 80 year-old patients
N
um
be
r o
f p
at
ie
nt
s
No CV events 
CV events
Figure 2 Bar chart shows the number of CV events in octoge-
narians (P80 years) and non octogenarians (<80 years).
P= 0.28.
Table 3 Data of CAS procedures.
Findings Number (%)
Technical succes 103 (99.04%)
Types of EPD
MoMa 42 (40.4%)
Spider ﬁlter 50 (48.1%)
Emboshield ﬁlter 9 (8.7%)
Accunet ﬁlter 2 (1.9%)
Balloon predilatation 15 (14.4%)
Types of used stents
Acculink (open cell) 50 (48.5%)
Precise (open cell) 20 (19.4%)
Prote´ge´ (open cell) 11 (10.6%)
Xact (closed cell) 9 (8.7%)
Cristallo ideale (hybrid) 13 (12.6%)
Stent design
Open cell 81 (78.6%)
Closed cell 9 (8.7%)
Hybrid 13 (12.5%)
Table 4 Number and percentage of peri-procedural adverse
events.
EVENTS Number Percentage (%)
Contralateral major stroke 1 0.9
Ipsilateral minor stroke 1 0.9
Ipsilateral TIA 3 2.8
MI 0 0
Amaurosis fugax 0 0
Death 0 0
Femoral access minor hematoma 1 0.9
ICA spasm 2 1.9
Prolonged hypotension 1 0.9
Table 5 Comparison between octogenarians and non
octogenarians.
Variables Octogenarians
(n= 21)
Non
octogenarians
(n= 79)
P value
Male gender 17 54 NS
DM 6 36 NS
HTN 20 66 NS
IHD 16 54 NS
Symptomatic patients 8 16 NS
Type III aortic arch 2 1 NS
Bovine arch 2 6 NS
Peri-procedural adverse events 2 3 NS
Aortic arch calciﬁcation 21 54 0.001
Lesion ulceration 5 27 NS
Length of the lesion >30 mm 0 2 NS
ICA stenosis >95% 5 4 NS
NS = non signiﬁcant.
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One month follow up visit at the outpatient clinic was avail-
able for 94 (94%) patients. Follow-up by phone calls was con-
ducted for the remaining 6 patients by a research coordinator.
During the period of 1 month follow up, there were no new
cerebrovascular, myocardial or retinal events. Also there were
no deaths during this period.
4.7. Relations between peri-procedural adverse events and other
variables
Periprocedural adverse events showed no signiﬁcant difference
regarding patient gender (P= 0.61). Two octogenarian pa-
tients got CV events (1 stroke and 1 TIA) with estimated event
rate = 7.6%, on the other hand 3 non octogenarian patients
got CV events (1 stroke and 2 TIAs) with estimated event
rate = 3.8%. Periprocedural adverse events did not show sig-
niﬁcant difference between octogenarians and non octogenar-
ians (P= 0.28) (Fig. 2).
The study revealed signiﬁcant difference between octogen-
arian and non octogenarian patients in relation to aortic arch
calciﬁcation (P= 0.02), however, it did not show signiﬁcantdifference regarding their gender, DM, HTN, IHD, symptom-
atic stenosis, Type III aortic arch, percentage of ICA stenosis
or length of the lesion (Table 5).
Patients in symptomatic and asymptomatic groups showed
no signiﬁcant difference regarding their age, gender, DM,
HTN, IHD, Type III aortic arch, bovine arch, or length of
the lesion. On the other hand they showed signiﬁcant differ-
ence regarding aortic arch calciﬁcation (P= 0.01), lesion
ulceration (P= 0.04) and percentage of ICA stenosis
(P= 0.02). Peri-procedural adverse events revealed no signiﬁ-
cant difference between symptomatic and asymptomatic pa-
tients (P= 0.06), (Table 6 and Fig. 3).
CAS procedures in patients with contralateral ICA total
occlusion showed no signiﬁcant increase in adverse events
compared with other procedures (P= 0.69). In the same con-
text, no signiﬁcant difference was found between the number
of CV events and aortic arch calciﬁcation (P= 0.14), lesion
ulceration (P= 0.64), lesion calciﬁcation (P= 0.06), degree
of ICA stenosis (P= 0.48) or length of the lesion (P= 0.62).
Comparing proximal protection (MoMa) with distal pro-
tection (Filters), the study revealed no signiﬁcant difference
regarding CV adverse events (P= 0.98).
Table 6 Comparison between symptomatic and asymptom-
atic patients.
Variables Symptomatic
(n= 24)
Asymptomatic
(n= 76)
P value
Male gender 17 56 NS
Octogenarian patients 8 13 NS
DM 10 34 NS
HTN 26 68 NS
IHD 19 54 NS
Type III aortic arch 1 2 NS
Bovine arch 3 6 NS
Periprocedural events 3 2 NS
Aortic arch calciﬁcation 23 51 0.01
Lesion ulceration 12 20 0.04
Length of the lesion >30 mm 0 2 NS
ICA stenosis >95% 6 4 0.02
NS = non signiﬁcance.
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Figure 3 Bar chart shows the number of CV events in asymp-
tomatic and symptomatic patients (P= 0.09).
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niﬁcant statistical difference between the cell design of the stent
and 30-day CV events (P= 0.22).
5. Discussion
Peri-procedural period (intra-procedural and during 1st month
after procedure) has special interest in CAS studies. Adverse
events that occur during that period represent the safety of
the procedure. In the current study peri-procedural adverse
events occurred in 5 (5%) patients: 1 (1%) major stroke, 1
(1%) minor stroke and 3 (3%) TIAs. The study showed no
cases of MI, retinal symptoms or deaths. Rate of adverse
events is comparable to many other registries; in ‘‘Acculink
for Revascularization of Carotids in High-Risk Patients’’ (AR-
CHeR) trial10 showed that, the composite rate of MI, stroke,
or death at 30 days = 8.3%. Also, ‘‘Carotid Acculink/Accunet
Post-Approval Trial to Uncover Unanticipated or Rare
Events’’ (CAPTURE) trial11 presented 30-day adverse event
rate of death, stroke and MI was 6.3%. Moreover, the recent
CREST study carried out by Brott et al.7 reported peri-proce-
dural incidence of primary end points (CV events, death and
MI) in patients treated by CAS = 5.2%.
Although 70% of patients had a history of coronary artery
disease, no peri-procedural MI was observed. Less invasiveapproach associated with percutaneous treatment, and use of
local anesthesia, seems to limit cardiac complications during
CAS in patients with combined carotid and coronary artery
disease.
Sex category did not show signiﬁcant statistical difference
regarding the 30-day outcome (P= 0.61) in concordance with
Roubin et al.12 who reported similar peri-procedural complica-
tion rates in male and female patients (P= 0.4). Also Werner
et al.13 showed no signiﬁcant difference in peri-procedural
events in relation to gender (P= 0.12).
In the current study, octogenarian and non octogenarians
were comparable in terms of gender, proportion of symptom-
atic patients, risk factors, Type III aortic arch degree of ste-
nosis and length of the lesion. However, they showed
signiﬁcant difference regarding the aortic arch calciﬁcations
which could be explained by the effect of aging process.
Lam et al.14 revealed higher incidence of aortic calciﬁcation
and adverse anatomical characteristics in octogenarians.
Age has been identiﬁed as a risk factor for adverse outcomes
in the periprocedural period in numerous studies. Gray
et al.15 in CAPTURE 2 trial showed that, 30-day death/
stroke rates were signiﬁcantly higher for octogenarians
(4.5%) than for non octogenarians (3.0%). In the current
study, peri-procedural rate of adverse events (TIA, stroke,
MI and death) was 7.6% in octogenarians and 3.8% in
non octogenarians. The higher rate of adverse events in octo-
genarians did not reach signiﬁcant difference. Lack of signif-
icance between octogenarians and non octogenarians could
be explained by the small number of patients in the octogen-
arian group and few adverse events as well as comparable
complex anatomical features.
Symptomatic patients usually have a greater burden of
unstable atherosclerotic plaques leading to increased potential
risk for embolization during CAS. However, many studies
have suggested that this embolic risk during CAS can be atten-
uated with the use of EPDs leading to a decrease in major clin-
ical events. In the current study, peri-procedural event rate of
stroke, MI and death was 1.3% in the asymptomatic patients
and was 4.1% in the symptomatic patients with no signiﬁcant
difference between them (P= 0.09). Rhee-Moore et al.16
showed no signiﬁcant difference in periprocedural stroke, MI
or death between symptomatic and asymptomatic patients.
Brott et al.7 in the CREST trial resulted in 30-day event
rate = 3.5% in asymptomatic patients and 6.7% in symptom-
atic patients.
Garg et al.17 carried out a systematic review of the literature
about stroke outcomes in protected and unprotected CAS and
indicated that, the use of EPDs has decreased the risk of peri-
procedural stroke. Nowadays the use of EPDs is recommended
in all CAS procedures. Choice between MoMa and ﬁlters is
usually based on the morphology of culprit lesion as well as
individual preference and familiarity. Current study presented
no signiﬁcant difference between MoMa and ﬁlters regarding
peri-procedural adverse events, however selection of devices
was not randomized. Montorsi et al.18 showed no signiﬁcant
difference in the number of embolic lesions in procedures with
MoMa compared with the procedures with FilterWire EZ
(Boston Scientiﬁc Corporation).
Intolerance to ICA occlusion with MoMa, was infrequent
and did not necessitate abortion of the procedures, this could
be explained by short ICA clamping time (5.9 ± 3.1 min). Rei-
mers et al.19 showed mild symptoms of intolerance and proce-
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tion for intermittent occlusion or shifting to a ﬁlter device.
Closed-cell stents have high scaffolding and wall-coverage
properties but its disadvantage is stiffness with poor conform-
ability and ﬂexibility, On the other hand, open-cell designs
tend to have a larger free-cell area with the advantages of high
conformability and ﬂexibility, but its disadvantages include
moderate scaffolding and wall-coverage properties. In our
study, the selection of stent design relied on plaque character-
istics and angulated ICA. Stent design revealed no signiﬁcant
difference regarding peri-procedural adverse outcome. Schil-
linger et al.20 reported no signiﬁcant difference in acute and
sub-acute neurological complications between closed cell and
open-cell design during CAS.
Interestingly, one of stroke cases had occurred in the con-
tralateral cerebral hemisphere which emphasizes the impor-
tance of catheter manipulation in the aortic arch as a
source of cerebral embolization. This is in agreement with
Maleuxa et al.21 who revealed Post-CAS procedures diffu-
sion-weighted (DW)-MRI new ischemic lesions in the contra-
lateral hemisphere in 26.3% and in the ipsilateral cerebral
hemisphere in 9% of cases and explained this ﬁnding by
manipulations of guidewire or catheters in the calciﬁc aortic
arch. In clinical trials, approximately 20% of clinical embolic
events associated with CAS occur in the contralateral cere-
bral circulation, which would not be expected to improve
with the available embolic protection devices.15
Current study showed no signiﬁcant increase in peri-proce-
dural events in patients with contralateral ICA total occlusion.
This ﬁnding is concordant with Touze et al.22 who showed no
signiﬁcant increase in peri-procedural adverse events during
CAS in patients with contralateral ICA occlusion.
Lesion ulceration, lesion calciﬁcation, degree of ICA steno-
sis or aortic arch calciﬁcation did not reveal a signiﬁcant in-
crease of peri-procedural adverse events. In the same
context, Sayeed et al.23 presented no signiﬁcant effect of lesion
ulceration, lesion calciﬁcation or degree of ICA stenosis on
peri-procedural adverse outcome of CAS.
6. Limitations
 The relatively small number of procedures as well as infre-
quency of neurological events.
 The study did not include intra-procedural transcranial
Doppler; so the true efﬁcacy of EPDs devices in prevention
of cerebral microemboli during the CAS could not be
evaluated.
 Absence of routine post procedural DW-MRI limited the
diagnosis of silent cerebral infarcts.
 Non-randomized selection of types of EPDs and stent cell
designs.
7. Conclusion
CAS with the use of EPD seems a feasible and safe procedure
with a low incidence of peri-procedural adverse events. CAS
procedures for octogenarians and for those with contralateral
ICA occlusion could be performed with acceptable risk.Conﬂict of interest
We have no conﬂict of interest to declare.
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